232 related articles for article (PubMed ID: 9198123)
21. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
Chuah M; Vandendriessche T
Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
[TBL] [Abstract][Full Text] [Related]
22. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
Bristol JA; Shirley P; Idamakanti N; Kaleko M; Connelly S
Mol Ther; 2000 Sep; 2(3):223-32. PubMed ID: 10985953
[TBL] [Abstract][Full Text] [Related]
23. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
[TBL] [Abstract][Full Text] [Related]
24. Hemophilia A--from basic science to clinical practice.
Klinge J; Ananyeva NM; Hauser CA; Saenko EL
Semin Thromb Hemost; 2002 Jun; 28(3):309-22. PubMed ID: 12098093
[TBL] [Abstract][Full Text] [Related]
25. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
Couto LB
Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
Chuah MK; Vandendriessche T
Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
[TBL] [Abstract][Full Text] [Related]
27. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
28. Preclinical gene therapy studies for hemophilia using adenoviral vectors.
Thorrez L; VandenDriessche T; Collen D; Chuah MK
Semin Thromb Hemost; 2004 Apr; 30(2):173-83. PubMed ID: 15118929
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S
Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919
[TBL] [Abstract][Full Text] [Related]
30. Factoring nonviral gene therapy into a cure for hemophilia A.
Gabrovsky V; Calos MP
Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922
[TBL] [Abstract][Full Text] [Related]
31. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
[TBL] [Abstract][Full Text] [Related]
33. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
Rawle FE; Lillicrap D
Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
[TBL] [Abstract][Full Text] [Related]
34. AAV-mediated gene therapy for hemophilia.
Couto LB; Pierce GF
Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
[TBL] [Abstract][Full Text] [Related]
35. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
36. New high-technology products for the treatment of haemophilia.
Pipe SW; Saint-Remy JM; Walsh CE
Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in hepatic gene transfer: more efficacy and less immunogenicity.
Herzog RW
Curr Opin Drug Discov Devel; 2005 Mar; 8(2):199-206. PubMed ID: 15782544
[TBL] [Abstract][Full Text] [Related]
38. Management of hemophilias--gene therapy to come?
Vajó Z; Sréter L
Acta Physiol Hung; 1996; 84(2):191-8. PubMed ID: 9046365
[TBL] [Abstract][Full Text] [Related]
39. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
Zhu F; Liu Z; Miao J; Qu H; Chi X
Sci China Life Sci; 2012 Jun; 55(6):521-6. PubMed ID: 22744182
[TBL] [Abstract][Full Text] [Related]
40. Haemophilia A gene therapy.
Connelly S; Kaleko M
Haemophilia; 1998 Jul; 4(4):380-8. PubMed ID: 9873758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
